Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum lysozyme in multiple myeloma.

E A Deo, J Brook

    The Journal of Laboratory and Clinical Medicine
    |November 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Serum lysozyme levels (SLLs) in multiple myeloma patients were similar to controls, but higher in those with renal impairment. SLLs decreased in severe granulocytopenia, indicating potential diagnostic value.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Women's engagement with community perinatal mental health services: a realist evaluation.

    BMC psychiatry·2024
    Same author

    Long-term exposure to traffic-related air pollution and stroke: A systematic review and meta-analysis.

    International journal of hygiene and environmental health·2022
    Same author

    The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).

    Clinical rheumatology·2019
    Same author

    The effect of individual radiographers on rates of attendance to breast screening: a 7-year retrospective study.

    Clinical radiology·2017
    Same author

    Linking near- and far-field hydrodynamic models for simulation of desalination plant brine discharges.

    Water science and technology : a journal of the International Association on Water Pollution Research·2013
    Same author

    Cytotoxicity of ambient air particles to rat lung macrophages: Comparison of cellular and functional assays.

    Toxicology in vitro : an international journal published in association with BIBRA·2010
    Same journal

    Studies on streptomycin; assay in body fluids.

    The Journal of laboratory and clinical medicine·2010
    Same journal

    Gastrocolic fistula; an experimental study.

    The Journal of laboratory and clinical medicine·2010
    Same journal

    An isolated heart perfusion system adapted to the determination of nongaseous metabolities; with sample data upon the isolated monkey heart.

    The Journal of laboratory and clinical medicine·2010
    Same journal

    A new type of glass cage for metabolism studies.

    The Journal of laboratory and clinical medicine·2010
    Same journal

    A simple electrocardiograph contact electrode for use with the smaller laboratory animal.

    The Journal of laboratory and clinical medicine·2010
    Same journal

    A primary standard for the colorimetric determination of hemoglobin.

    The Journal of laboratory and clinical medicine·2010
    See all related articles

    Area of Science:

    • Biochemistry
    • Hematology
    • Oncology

    Background:

    • Multiple myeloma is a cancer of plasma cells.
    • Serum lysozyme levels (SLLs) are a potential biomarker in hematologic malignancies.

    Purpose of the Study:

    • To evaluate SLLs in multiple myeloma patients.
    • To assess the correlation of SLLs with disease characteristics and clinical status.

    Main Methods:

    • Turbidometric assay used to measure SLLs in 33 male multiple myeloma patients over 7 years.
    • Comparison of SLLs between patients and normal controls.
    • Analysis of SLLs in relation to myeloma subtype, age, renal function, and granulocytopenia.

    Main Results:

    • Median SLLs in myeloma patients (16 µg/mL) were similar to controls (14.4 ± 3.5 µg/mL), especially when excluding patients with renal impairment.

    Related Experiment Videos

  • Elevated SLLs were observed in patients with severe renal disease.
  • SLLs decreased during severe granulocytopenia (<500 cells/mm³) and normalized with recovery.
  • No significant changes in SLLs were noted during infections or mild granulocytopenia.

    • Conclusions:

    • SLLs are not significantly different in multiple myeloma patients compared to controls, except in cases of renal impairment.
    • SLLs may serve as an indicator of renal function and severe granulocytopenia in multiple myeloma.
    • Further research could explore SLLs as a prognostic or monitoring biomarker.